NNC0113-6856

· Novo Nordisk A/S

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for NNC0113-6856, covering 2025-06-18 to 2025-12-31. Get the full timeline:

Most recent: Clinical Trial Update: A Research Study of a New Medicine NNC0113-6856 in Healthy Males [Phase 1]